Publications by authors named "Jen Timoshanko"

Claim this Profile
R
Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.
Serge Ferrari, Donald Betah, Robert G Feldman, Bente L Langdahl, Mary Oates, Jen Timoshanko

J Clin Endocrinol Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab improves microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis.
Michael R McClung, Donald Betah, Benjamin Z Leder, David L Kendler, Mary Oates, Jen Timoshanko

J Bone Miner Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.
Felicia Cosman, Mary Oates, Donald Betah, Jen Timoshanko, Zhenxun Wang

J Bone Miner Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial.
Nancy E Lane, Donald Betah, Cynthia Deignan, Mary Oates, Zhenxun Wang, Jen Timoshanko

ACR Open Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk.
Michael R McClung, Donald Betah, Cynthia Deignan, Yifei Shi, Jen Timoshanko

Endocr Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Bente Langdahl, Lorenz C Hofbauer, Serge Ferrari, Zhenxun Wang, Astrid Fahrleitner-Pammer, Jen Timoshanko

Osteoporos Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
Jonas Banefelt, Jen Timoshanko, Emma Söreskog, Gustaf Ortsäter, Alireza Moayyeri

J Bone Miner Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal responses to romosozumab after 12 months of denosumab.
Michael R McClung, Michael A Bolognese, Jacques P Brown, Jean-Yves Reginster, Bente L Langdahl, Jen Timoshanko

JBMR Plus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis